02925nam 2200649Ia 450 991077786740332120230721031520.00-309-18015-51-280-74245-397866107424550-309-66345-89780309102803(CKB)1000000000471151(EBL)3378165(SSID)ssj0000226803(PQKBManifestationID)11176488(PQKBTitleCode)TC0000226803(PQKBWorkID)10264093(PQKB)10696753(MiAaPQ)EBC3378165(Au-PeEL)EBL3378165(CaPaEBR)ebr10156535(CaONFJC)MIL74245(OCoLC)923276351(EXLCZ)99100000000047115120060929d2007 uy 0engurcn|||||||||txtccrPreventing HIV infection among injecting drug users in high risk countries[electronic resource] an assessment of the evidence /Committee on the Prevention of HIV Infection among Injecting Drug Users in High-Risk Countries, Board on Global Health, Institute of Medicine of the National AcademiesWashington, D.C. National Academies Pressc20071 online resource (299 p.)Description based upon print version of record.0-309-10280-4 Includes bibliographical references.""Front Matter""; ""Reviewers""; ""Acknowledgments""; ""Contents""; ""Acronyms and Abbreviations""; ""Summary""; ""Introduction""; ""1 HIV/AIDS in Injecting Drug Users""; ""2 Treatment for Drug Dependence""; ""3 Sterile Needle and Syringe Access, and Outreach and Education""; ""4 Taking Action""; ""Appendixes""; ""Appendix A Agenda for Information-Gathering Meeting, Geneva, December 2005""; ""Appendix B Literature Search Strategies""; ""Appendix C Country Case Examples""""Appendix D Tables Summarizing the Evidence on Multi-Component HIV Prevention Programs That Include Needle and Syringe Exchange (NSE)""""Appendix E Additional Thoughts on a Community Randomized Trial of Multi-Component HIV Prevention Programs""; ""Appendix F Biographies""HIV infectionsPreventionAIDS (Disease)Needle exchange programsIntravenous drug abuseHIV infectionsPrevention.AIDS (Disease)Needle exchange programs.Intravenous drug abuse.614.5Institute of Medicine (U.S.).Board on Global Health.National Academies Press (U.S.)MiAaPQMiAaPQMiAaPQBOOK9910777867403321Preventing HIV infection among injecting drug users in high risk countries3716426UNINA